GlaxoSmithKline

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Public

Established: 1929-01-01

Employees: 70.2K

Market Cap: $90B

Website: http://www.gsk.com

Introduction: GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Clinical Trials

A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa

Phase 2

Completed

Conditions: Infections, Rotavirus

Interventions: Biological: Placebo
Biological: Rotarix
Biological: Tritanrix-HB+Hib
Biological: Polio Sabin

First Posted Date: 2005-12-09

Last Posted Date: 2020-11-23

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 100

Registration Number: NCT00263666

Locations: 🇿🇦
GSK Investigational Site, Ga-Rankuwa, South Africa

Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorix™ in Toddlers (13-14 m) Primed With 3 Doses of Hib and MenC-CRM197

Phase 3

Completed

Conditions: Neisseria Meningitidis
Haemophilus Influenzae Type b

First Posted Date: 2005-12-09

Last Posted Date: 2016-09-21

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 297

Registration Number: NCT00263653

Locations: 🇪🇸
GSK Investigational Site, Velez, Malaga, Spain

In-patient Study in Patients With Type 2 Diabetes Mellitus

Phase 1

Completed

Conditions: Type 2 Diabetes Mellitus
Diabetes Mellitus, Type 2

First Posted Date: 2005-12-01

Last Posted Date: 2012-06-04

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 30

Registration Number: NCT00259896

Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus

Phase 2

Completed

Conditions: Adenocarcinoma

First Posted Date: 2005-12-01

Last Posted Date: 2009-05-18

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 24

Registration Number: NCT00259987

Locations: 🇵🇪
GSK Investigational Site, Lima, Peru

A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors

Phase 1

Completed

Conditions: Lung Cancer, Small Cell

Interventions: Drug: topotecan

First Posted Date: 2005-12-01

Last Posted Date: 2017-11-14

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 107

Registration Number: NCT00259935

Locations: 🇳🇱
GSK Investigational Site, Utrecht, Netherlands

Combination Of PAXIL Tablet And Benzodiazepines

Phase 4

Completed

Conditions: Mental Disorders

Interventions: Drug: paroxetine

First Posted Date: 2005-12-01

Last Posted Date: 2017-01-18

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 150

Registration Number: NCT00259883

Locations: GSK Investigational Site

Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD)

Completed

Conditions: Pulmonary Disease, Chronic Obstructive
Infections, Bacterial

Interventions: Other: GSK questionnaire
Other: St. George's Respiratory Questionnaire
Other: Acute Short Form 12 version 2
Other: Global Efficacy questionnaire